Insulin Glargine Market Analysis Across Type 1 and Type 2 Diabetes

добавлена новая статья Другое

2026-06-25 05:50:03 - Перевод -

The global insulin glargine market was valued at USD 2.47 billion in 2025 and is projected to grow from USD 2.62 billion in 2026 to USD 4.32 billion by 2034, registering a CAGR of 6.43% during the forecast period from 2026 to 2034. Insulin glargine remains an important long-acting basal insulin therapy used in the management of type 1 and type 2 diabetes. Demand is being supported by...

0 Комментарии 0 Поделились 89 Просмотры 0 предпросмотр